280E Updates: Rescheduling, Amending Returns, and Why Timing Matters - Sign up for our free webinar now!
280E Updates: Rescheduling, Amending Returns, and Why Timing Matters - Sign up for our free webinar now!
Tag: CBT > Cannabis Schedule | Cannabis Business Times
Subscribe
Sign In
Tag: CBT > Cannabis Schedule
Cannabis Rescheduling
Prohibitionists Punch Back at Cannabis Rescheduling Hearing
Anti-rescheduling participants who oppose the Schedule III proposal attempt to expose flaws in a scientific and medical evaluation and discredit DEA witnesses.
July 1, 2026
Cannabis Rescheduling
DEA Plans to Call Pain Management Doctor, FDA Official to Testify at Cannabis Reschedule Hearing
The Drug Enforcement Administration filed a prehearing statement summarizing its two proposed witnesses’ testimony.
June 26, 2026
Cannabis Rescheduling
DEA Judge Sets Cannabis Hearing Schedule, Won’t Consider More Participants
The administrative law judge declined to consider pleas from non-parties to participate in the rescheduling hearing for the proposed Schedule III rule.
June 25, 2026
Cannabis Rescheduling
Should DEA’s One-Sided Cannabis Rescheduling Hearing Be Reason for Concern?
The government may lack a sufficient administrative record to defend a Schedule III decision in judicial review without any pro-rescheduling participants.
June 24, 2026
Cannabis Rescheduling
DEA Names 7 Anti-Rescheduling Parties for Cannabis Hearing, Zero Pro Parties
Derek C. Julius will be the DEA’s chief administrative law judge to oversee the hearing of a proposed rule to reclassify cannabis as a Schedule III drug.
June 19, 2026
Hemp-Derived Cannabinoids
White House’s ‘New Legal Authority’ for Hemp THC Products Leads CBT’s Top Stories in May
The Trump administration’s drug control strategy indicated enforcement of intoxicating hemp products that have largely gone unregulated.
May 27, 2026
Cannabis Rescheduling
3 Immediate Implications of Schedule III Leads
CBT’s
Top Stories in April
Vicente LLP founding partner Brian Vicente broke down the implications, and what else may unfold, in this month’s most-read article.
April 29, 2026
The Last Word
Trulieve CEO ‘Not Concerned’ by DEA’s Middleman Role in Schedule III Order
Kim Rivers dives into the feds’ impending access to her company’s facilities and other treaty obligations, as well as 280E taxes, product development and scientific research.
April 24, 2026
Cannabis Rescheduling
Cannabis Industry Stakeholders React to Trump DOJ’s Rescheduling Order, New Hearing
The Department of Justice’s two-phase rescheduling plan includes an immediate order and a new, expedited hearing process.
April 23, 2026
Cannabis Rescheduling
Trump Pleads to ‘Please’ Get Cannabis Rescheduling Done 4 Months After Order
The president claimed his administration is ‘slow-walking’ a cannabis rescheduling order he issued in December.
April 20, 2026
Cannabis Rescheduling
US Congressman Presses DOJ, DEA Heads on Cannabis Rescheduling Timeline
Democratic Rep. Steve Cohen sent a letter to Attorney General Pam Bondi and DEA Administrator Terry Cole asking for a status update.
March 27, 2026
Cannabis Rescheduling
The Rescheduling of Marijuana Is Not Happening Any Time Soon (Opinion)
Don’t hold your breath: Trump’s December 2025 Schedule III order is
window dressing for doing nothing.
February 5, 2026
Page 1 of 10
Next Page